Role of the heparin-binding domain in intracellular trafficking of sHB-EGF

Heparin-binding EGF-like growth factor (HB-EGF) is a member of the epidermal growth factor fami­ly that was proven as a potent mitogen and chemoattractant. HB-EGF mediated EGFR activation is a key event in the stimulation of gene expression, cell migration and proliferation during both normal and pa...

Full description

Bibliographic Details
Main Authors: O. I. Krynina, K. Yu. Manoilov, D. V. Kolybo, S. V. Komisarenko
Format: Article
Language:English
Published: National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry 2019-08-01
Series:The Ukrainian Biochemical Journal
Subjects:
Online Access:http://ukrbiochemjournal.org/wp-content/uploads/2019/06/Krynina_4_19.pdf
_version_ 1797641760035307520
author O. I. Krynina
K. Yu. Manoilov
D. V. Kolybo
S. V. Komisarenko
author_facet O. I. Krynina
K. Yu. Manoilov
D. V. Kolybo
S. V. Komisarenko
author_sort O. I. Krynina
collection DOAJ
description Heparin-binding EGF-like growth factor (HB-EGF) is a member of the epidermal growth factor fami­ly that was proven as a potent mitogen and chemoattractant. HB-EGF mediated EGFR activation is a key event in the stimulation of gene expression, cell migration and proliferation during both normal and pathogenic physiological processes. The main goal of this research was to reveal the role of the heparin-binding domain of HB-EGF in the ligand-receptor formation and its further internalization to the cytoplasm. We used fluorescently-labeled recombinant derivative of soluble HB-EGF and its truncated form (sHB-EGFΔ84–106) with deletion of the heparin-binding domain. Firstly, the binding kinetics of two forms of sHB-EGF to its cell surface receptors was determined using flow cytometry. To determine how the absence of heparin-binding domain in the structure of HB-EGF affects its internalization, we analyzed the endocytosis process of EGFP-sHB-EGFΔ84–106 and EGFP-sHB-EGF complexes by confocal microscopy. It was found that the full-size form of HB-EGF is characterized by a lower intensity of translocation to the cytoplasm in comparison to HBD-deleted form. Thus, differences in the trafficking of the full-size or truncated forms of sHB-EGF in the cell cytoplasm may reflect the mechanisms of extracellular matrix influence on the biological activity of sHB‑EGF.
first_indexed 2024-03-11T13:50:16Z
format Article
id doaj.art-7de8dc7ab6ab40b08ac2a85f2198e177
institution Directory Open Access Journal
issn 2409-4943
2413-5003
language English
last_indexed 2024-03-11T13:50:16Z
publishDate 2019-08-01
publisher National Academy of Sciences of Ukraine, Palladin Institute of Biochemistry
record_format Article
series The Ukrainian Biochemical Journal
spelling doaj.art-7de8dc7ab6ab40b08ac2a85f2198e1772023-11-02T09:08:08ZengNational Academy of Sciences of Ukraine, Palladin Institute of BiochemistryThe Ukrainian Biochemical Journal2409-49432413-50032019-08-01914263210.15407/ubj91.04.026Role of the heparin-binding domain in intracellular trafficking of sHB-EGFO. I. Krynina0K. Yu. Manoilov1D. V. Kolybo2S. V. Komisarenko3Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine, KyivPalladin Institute of Biochemistry, National Academy of Sciences of Ukraine, KyivPalladin Institute of Biochemistry, National Academy of Sciences of Ukraine, KyivPalladin Institute of Biochemistry, National Academy of Sciences of Ukraine, KyivHeparin-binding EGF-like growth factor (HB-EGF) is a member of the epidermal growth factor fami­ly that was proven as a potent mitogen and chemoattractant. HB-EGF mediated EGFR activation is a key event in the stimulation of gene expression, cell migration and proliferation during both normal and pathogenic physiological processes. The main goal of this research was to reveal the role of the heparin-binding domain of HB-EGF in the ligand-receptor formation and its further internalization to the cytoplasm. We used fluorescently-labeled recombinant derivative of soluble HB-EGF and its truncated form (sHB-EGFΔ84–106) with deletion of the heparin-binding domain. Firstly, the binding kinetics of two forms of sHB-EGF to its cell surface receptors was determined using flow cytometry. To determine how the absence of heparin-binding domain in the structure of HB-EGF affects its internalization, we analyzed the endocytosis process of EGFP-sHB-EGFΔ84–106 and EGFP-sHB-EGF complexes by confocal microscopy. It was found that the full-size form of HB-EGF is characterized by a lower intensity of translocation to the cytoplasm in comparison to HBD-deleted form. Thus, differences in the trafficking of the full-size or truncated forms of sHB-EGF in the cell cytoplasm may reflect the mechanisms of extracellular matrix influence on the biological activity of sHB‑EGF.http://ukrbiochemjournal.org/wp-content/uploads/2019/06/Krynina_4_19.pdfendocytosisepidermal growth factor receptorheparin-binding EGF-like growth factor
spellingShingle O. I. Krynina
K. Yu. Manoilov
D. V. Kolybo
S. V. Komisarenko
Role of the heparin-binding domain in intracellular trafficking of sHB-EGF
The Ukrainian Biochemical Journal
endocytosis
epidermal growth factor receptor
heparin-binding EGF-like growth factor
title Role of the heparin-binding domain in intracellular trafficking of sHB-EGF
title_full Role of the heparin-binding domain in intracellular trafficking of sHB-EGF
title_fullStr Role of the heparin-binding domain in intracellular trafficking of sHB-EGF
title_full_unstemmed Role of the heparin-binding domain in intracellular trafficking of sHB-EGF
title_short Role of the heparin-binding domain in intracellular trafficking of sHB-EGF
title_sort role of the heparin binding domain in intracellular trafficking of shb egf
topic endocytosis
epidermal growth factor receptor
heparin-binding EGF-like growth factor
url http://ukrbiochemjournal.org/wp-content/uploads/2019/06/Krynina_4_19.pdf
work_keys_str_mv AT oikrynina roleoftheheparinbindingdomaininintracellulartraffickingofshbegf
AT kyumanoilov roleoftheheparinbindingdomaininintracellulartraffickingofshbegf
AT dvkolybo roleoftheheparinbindingdomaininintracellulartraffickingofshbegf
AT svkomisarenko roleoftheheparinbindingdomaininintracellulartraffickingofshbegf